Erin McGuinness

News

Placebo Run-In Periods in Randomized Clinical Trials of Antidepressants Not Effective

11/18/2021

Although there are few proven benefits, PRI periods are common in RCTs for antidepressants, according to new research published in JAMA Psychiatry.

Although there are few proven...

11/18/2021

Psych Congress Network

News

Pregnancy Does Not Affect Long-Term Disability Accumulation in Patients With Multiple Sclerosis

11/19/2021

Erin McGuinness ;

Pregnancy does not influence long-term disability accumulation or disease course in women with multiple sclerosis (MS), according to recent findings published in Multiple Sclerosis Journal.

Pregnancy does not influence...

11/19/2021

Neurology

News

New Research Helps Identify Common Genetic Risk for Essential Tremor

01/07/2022

Erin McGuinness ;

New findings may help to inform ET biology and identify new genes, according to an association study and meta-analysis published in JAMA Neurology.

New findings may help to inform...

01/07/2022

Neurology

News

Opioid Overdoses Related to Neurocognitive Impairment

09/10/2021

Erin McGuinness ;

There is an association between non-fatal opioid overdoses and brain injuries/neurocognitive impairments, according to a systematic review summarizing research on opioid-related overdose.

There is an association between...

09/10/2021

Psych Congress Network

News

Lipid-Specific IgM Oligoclonal Bands Can Predict Aggressive Multiple Sclerosis Early

08/11/2021

Erin McGuinness ;

Intrathecal immunoglobulin M synthesis (ITMS), a biomarker for poor prognosis in patients with multiple sclerosis (MS), can predict aggressive MS at disease onset when detected by lipid-specific IgM oligoclonal bands (LS-OCMBs), according to...

Intrathecal immunoglobulin M...

08/11/2021

Neurology

News

Studies Show Success with Cariprazine as Adjunctive Treatment of Major Depressive Disorder

11/10/2021

Erin McGuinness ;

AbbVie announced positive results from a Phase 3 study in which cariprazine (VRAYLAR) met the primary endpoint as an adjunctive treatment of major depressive disorder.

AbbVie announced positive...

11/10/2021

Psych Congress Network

News

NAMI Hosting REIMAGINE Week of Action to Advocate for Improvement of Crisis Services

11/15/2021

Erin McGuinness ;

The National Alliance on Mental Illness is hosting a week of virtual events November 15-19 aims to advocate for the improvement of crisis services.

The National Alliance on Mental...

11/15/2021

Psych Congress Network

News

Physical Activity Associated With Reduced Mortality Rate for Patients With Parkinson Disease

11/16/2021

Erin McGuinness ;

Physical activity is associated with reduced all-cause mortality in patients with Parkinson disease (PD), according to new findings published in JAMA Neurology.

Physical activity is associated...

11/16/2021

Neurology

News

Internet-Delivered Mindfulness-Based Intervention Beneficial for Patients With MS and Depression

02/25/2022

Erin McGuinness ;

For patients with multiple sclerosis (MS), internet-delivered mindfulness-based intervention (MBI) can improve symptoms of depression, according to recent study findings.

For patients with multiple...

02/25/2022

Neurology

News

Lumateperone Safe, Effective for Improving Depression Symptoms in Patients with Bipolar Disorders

09/27/2021

Erin McGuinness ;

Lumateperone can safely improve symptoms for patients with bipolar I or bipolar II disorder experiencing major depressive episodes, according to new research published in the American Journal of Psychiatry.

Lumateperone can safely improve...

09/27/2021

Psych Congress Network